FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for producing drug microcapsules by non-solvent addition, differing by the fact that the drugs are presented by cephalosporin preparations, while the coating is human leukocyte interferon α and β, which is deposited from an aqueous solution by adding isopropanole as a non-solvent and acetone at 25°C.
EFFECT: invention provides simplifying and accelerating the process of microcapsules, reducing production loss (higher mass yield).
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538807C1 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538678C2 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2538668C1 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2558077C2 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2555466C2 |
METHOD OF PRODUCING MICROCAPSULES OF CEPHALOSPORIN ANTIBIOTICS IN INTERFERONS | 2013 |
|
RU2580614C2 |
METHOD FOR PREPARING CEPHALOSPORIN MICROCAPSULES IN INTERFERON | 2012 |
|
RU2500404C2 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2539898C2 |
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2545723C2 |
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2554277C2 |
Authors
Dates
2015-01-10—Published
2013-06-25—Filed